TScan Therapeutics Inc TCRX:NASDAQ

RT Quote | USD
Last | 11/29/22 EST
2.10quote price arrow down-0.21 (-9.09%)
Volume
29,432
52 week range
1.60 - 7.90
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.31
  • 52 Week High7.90
  • 52 Week High Date11/30/21
  • 52 Week Low1.60
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap50.567M
  • Shares Out24.08M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.33

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.31
  • 52 Week High7.90
  • 52 Week High Date11/30/21
  • 52 Week Low1.60
  • 52 Week Low Date05/09/22
  • Market Cap50.567M
  • Shares Out24.08M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-53.33

RATIOS/PROFITABILITY

  • EPS (TTM)-2.58
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-0.74
  • EBITDA (TTM)-57.394M
  • ROE (TTM)-42.44%
  • Revenue (TTM)13.294M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-464.10%
  • Debt To Equity (MRQ)24.92%

EVENTS

  • Earnings Date03/09/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TScan Therapeutics Inc

 

Profile

MORE
TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. The Company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. The...
Timothy Barberich
Non-Executive Independent Chairman
David Southwell
President, Chief Executive Officer, Director
Gavin Macbeath Ph.D.
Chief Scientific and Operations Officer
Brian Silver J.D.
Chief Financial Officer, Treasurer
Ann Hargraves
Vice President - Human Resources
Leiden Dworak CPA
Vice President - Finance
Address
880 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ORTX
Orchard Therapeutics PLC
0.446+0.001+0.2247%
HOOK
HOOKIPA Pharma Inc
1.04+0.04+4.00%
SLDB
Solid Biosciences Inc
6.58-0.06-0.90%
ISR
Isoray Inc
0.3849-0.0006-0.1556%
HOWL
Werewolf Therapeutics Inc
1.76-0.04-2.22%